Edmund Harrigan Net Worth & Insider Trades

Edmund Harrigan - Director, Phasebio Pharmaceuticals Inc

As of May 20, 2022

What is Edmund Harrigan's Net Worth?

The current estimated net worth of Phasebio Pharmaceuticals Inc's Director, Edmund Harrigan, is estimated to be about $25.26M . Edmund Harrigan owns about 6,000 units of Phasebio Pharmaceuticals Inc common stock. In the last 4 years at Phasebio Pharmaceuticals Inc, Edmund Harrigan has sold an estimated value of $0 worth.

What is Edmund Harrigan's Past Insider Trading?

Edmund Harrigan's largest purchase order was 6,000 units , worth over $24.72K on December 4, 2020. In total, Edmund Harrigan has made about 6 transactions over 4 years of their time at Phasebio Pharmaceuticals Inc. Edmund Harrigan usually trades in December, May and June, with the busiest year in 2020.

EDMUND HARRIGAN

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Phasebio Pharmaceuticals Inc's Past Insider Trades?

Phasebio Pharmaceuticals Inc's most recent insider trade came on October 26, 2022 by New Enterprise Associates Lp, Nea Partners Limited Partnership, Nea GP Ltd, Scott Sandell, Patrick Kerins and Forest Baskett who sold 1,784,109 units worth $262.26K . In the last 4 years, insiders at Phasebio Pharmaceuticals Inc have sold an estimated value of $355.73K and bought an estimated value of $15.77M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Jonathan Mow, Chief Executive Officer,  John P Sharp, Chief Financial Officer,  and Clay Thorp, Director .

PhaseBio Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1